ArticleFoods (Basel, Switzerland)2026
A Novel Oral Film Formulation for Jujuboside: Response Surface Optimization of Preparation Parameters and Performance Evaluation.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Jujuboside is an active saponin with anxiolytic and sedative effects, but its oral bioavailability is extremely low. This study prepared an oral film to achieve rapid absorption through the oral mucosa. Using jujuboside as the raw material, the mass ratio of vinyl alcohol polymer to microbial polysaccharide, the ratio of propylene glycol to glycerol and the amount of cellulose ether were selected as influencing factors. On the basis of single-factor experiments, the response surface method was employed to optimize the preparation process of jujuboside oral films, and the effects of these factors on disintegration time and flexibility of the films were investigated. Meanwhile, the content uniformity of jujuboside A and γ-aminobutyric acid in the films was determined by high-performance liquid chromatography. Results showed that the optimized jujuboside oral film had complete molding, a smooth surface, good flexibility, a disintegration time of 25 s in simulated oral environment, and acceptable content uniformity of jujuboside A and γ-aminobutyric acid. The oral film can disintegrate rapidly and release the drug in the oral cavity, and is designed for oromucosal delivery. This oral film is convenient to take, particularly suitable for children, the elderly and patients with dysphagia, providing a new strategy for the clinical application of jujuboside.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.